Gender balance in cardiovascular research: importance to women's health.
作者信息
Dougherty Anne Hamilton
机构信息
Department of Internal Medicine, Cardiology Division, The University of Texas Health Science Center at Houston, Houston, Texas 77030, USA.
出版信息
Tex Heart Inst J. 2011;38(2):148-50.
Abstract
摘要
相似文献
1
Gender balance in cardiovascular research: importance to women's health.心血管研究中的性别平衡：对女性健康的重要性。
Tex Heart Inst J. 2011;38(2):148-50.
2
How the American Heart Association helped change women's heart health.美国心脏协会如何助力改变女性心脏健康状况。
Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S60-2. doi: 10.1161/CIRCOUTCOMES.115.001734. Epub 2015 Feb 24.
3
Women in clinical research: what we need for progress.临床研究中的女性：取得进展我们所需的因素。
Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S1-3. doi: 10.1161/CIRCOUTCOMES.115.001756. Epub 2015 Feb 24.
4
Why Are Young Black Women at High Risk for Cardiovascular Disease?为什么年轻黑人女性患心血管疾病的风险很高？
Circulation. 2019 Feb 19;139(8):1003-1004. doi: 10.1161/CIRCULATIONAHA.118.037689.
5
Difference or disparity: will big data improve our understanding of sex and cardiovascular disease?差异或差距：大数据能否增进我们对性别与心血管疾病的理解？
Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S52-5. doi: 10.1161/CIRCOUTCOMES.115.001701. Epub 2015 Feb 24.
6
State of the Heart for Women.女性心脏状况
Circulation. 2019 Feb 19;139(8):1121-1123. doi: 10.1161/CIRCULATIONAHA.118.039372.
7
Women in interventions: a win for cardiovascular medicine.参与干预措施的女性：心血管医学的一项成果
Catheter Cardiovasc Interv. 2010 Mar 1;75(4):648-50. doi: 10.1002/ccd.22454.
8
Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?心血管疾病与认知障碍中的性别差异：女性的另一种健康差距？
J Am Heart Assoc. 2019 Oct;8(19):e013154. doi: 10.1161/JAHA.119.013154. Epub 2019 Sep 24.
9
Cardiovascular Disease in Women.女性心血管疾病
Methodist Debakey Cardiovasc J. 2017 Oct-Dec;13(4):183-184. doi: 10.14797/mdcj-13-4-183.
10
Building solutions for cardiovascular disease in women.为女性心血管疾病构建解决方案。
Tex Heart Inst J. 2013;40(3):285-7.
引用本文的文献
1
'Information is power': A qualitative exploration of co-producing education resources about cardiovascular disease in partnership with women living with lupus.“信息就是力量”：与狼疮患者女性合作共同制作心血管疾病教育资源的质性探索
Womens Health (Lond). 2025 Jan-Dec;21:17455057251351736. doi: 10.1177/17455057251351736. Epub 2025 Jul 4.
2
Depression, anxiety, and quality of life as predictors of rehospitalization in patients with chronic heart failure.抑郁、焦虑和生活质量对慢性心力衰竭患者再住院的预测作用。
BMC Cardiovasc Disord. 2023 Oct 27;23(1):525. doi: 10.1186/s12872-023-03500-8.
3
A review of the historical use of sex as a biological variable in the .对生物学变量性别在 中的历史应用的回顾。
Am J Physiol Heart Circ Physiol. 2023 Oct 1;325(4):H768-H773. doi: 10.1152/ajpheart.00278.2023. Epub 2023 Aug 18.
4
Defining the reference range for right ventricular systolic strain by echocardiography in healthy subjects: A meta-analysis.超声心动图定义健康受试者右心室收缩期应变参考范围的荟萃分析。
PLoS One. 2021 Aug 20;16(8):e0256547. doi: 10.1371/journal.pone.0256547. eCollection 2021.
5
The Underrepresentation of Females in Studies Assessing the Impact of High-Dose Exercise on Cardiovascular Outcomes: a Scoping Review.评估高剂量运动对心血管结局影响的研究中女性代表性不足：一项范围综述
Sports Med Open. 2021 Apr 29;7(1):30. doi: 10.1186/s40798-021-00320-y.
6
Sex Differences in Advanced Cardiac MRI Assessment.心脏磁共振成像高级评估中的性别差异。
Radiol Cardiothorac Imaging. 2020 Feb 27;2(1):e190250. doi: 10.1148/ryct.2020190250. eCollection 2020 Feb.
7
Cardiovascular disease in women: insights from magnetic resonance imaging.女性心血管疾病：磁共振成像的新视角。
J Cardiovasc Magn Reson. 2020 Sep 28;22(1):71. doi: 10.1186/s12968-020-00666-4.
8
Association of Serum Adiponectin with Intima Media Thickness of Dorsalis Pedis Artery and Macroangiopathy in Type 2 Diabetes.血清脂联素与 2 型糖尿病患者足背动脉内中膜厚度及大血管病变的关系。
J Diabetes Res. 2020 Jan 3;2020:4739271. doi: 10.1155/2020/4739271. eCollection 2020.
9
The Gender Impact on Morphogenetic Variability in Coronary Artery Disease: A Preliminary Study.性别对冠状动脉疾病形态发生变异性的影响：一项初步研究。
J Clin Med. 2018 May 3;7(5):103. doi: 10.3390/jcm7050103.
本文引用的文献
1
Representation of women in randomized clinical trials of cardiovascular disease prevention.心血管疾病预防随机临床试验中的女性代表性。
Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):135-42. doi: 10.1161/CIRCOUTCOMES.110.868307. Epub 2010 Feb 16.
2
Heart disease and stroke statistics--2010 update: a report from the American Heart Association.《2010年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2010 Feb 23;121(7):e46-e215. doi: 10.1161/CIRCULATIONAHA.109.192667. Epub 2009 Dec 17.
3
Status of women in cardiovascular clinical trials.女性在心血管临床试验中的状况。
Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):279-83. doi: 10.1161/ATVBAHA.108.179796. Epub 2009 Feb 16.
4
Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study.1950年至1999年冠心病死亡率和心源性猝死的时间趋势：弗雷明汉心脏研究
Circulation. 2004 Aug 3;110(5):522-7. doi: 10.1161/01.CIR.0000136993.34344.41. Epub 2004 Jul 19.
5
Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute.由美国国立心肺血液研究所资助的心血管临床试验中女性受试者的招募情况。
N Engl J Med. 2000 Aug 17;343(7):475-80. doi: 10.1056/NEJM200008173430706.
6
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.雌激素加孕激素用于绝经后妇女冠心病二级预防的随机试验。心脏与雌激素/孕激素替代研究（HERS）研究组
JAMA. 1998 Aug 19;280(7):605-13. doi: 10.1001/jama.280.7.605.
7
8
Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population.两性冠心病发病率和死亡率模式：对弗雷明汉人群的26年随访
Am Heart J. 1986 Feb;111(2):383-90. doi: 10.1016/0002-8703(86)90155-9.
Zotero 插件